Literature DB >> 20832368

Maximising the public health benefit of antimalarials.

Ric N Price, Nicholas M Douglas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20832368      PMCID： PMC4627581          DOI： 10.1016/S1473-3099(10)70192-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  12 in total

1.  Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.

Authors:  Frank Smithuis; Moe Kyaw Kyaw; Ohn Phe; Khin Zarli Aye; Linn Htet; Marion Barends; Niklas Lindegardh; Thida Singtoroj; Elizabeth Ashley; Saw Lwin; Kasia Stepniewska; Nicholas J White
Journal:  Lancet       Date:  2006-06-24       Impact factor: 79.321

2.  Can treatment of P. vivax lead to a unexpected appearance of falciparum malaria?

Authors:  D P Mason; S Krudsood; P Wilairatana; P Viriyavejakul; U Silachamroon; W Chokejindachai; P Singhasivanon; S Supavej; F E McKenzie; S Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2001-03       Impact factor: 0.267

3.  In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.

Authors:  Seif A Shekalaghe; Roel ter Braak; Modibo Daou; Reginald Kavishe; Wouter van den Bijllaardt; Sven van den Bosch; Jan B Koenderink; Adrian J F Luty; Christopher J M Whitty; Chris Drakeley; Robert W Sauerwein; Teun Bousema
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

Review 4.  Tolerance is the key to understanding antimalarial drug resistance.

Authors:  Ian M Hastings; William M Watkins
Journal:  Trends Parasitol       Date:  2006-01-10

5.  Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.

Authors:  A Ratcliff; H Siswantoro; E Kenangalem; R Maristela; R M Wuwung; F Laihad; E P Ebsworth; N M Anstey; E Tjitra; R N Price
Journal:  Lancet       Date:  2007-03-03       Impact factor: 79.321

Review 6.  Artemisinin combination therapy for vivax malaria.

Authors:  Nicholas M Douglas; Nicholas M Anstey; Brian J Angus; Francois Nosten; Ric N Price
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

7.  Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.

Authors:  Frank Smithuis; Moe Kyaw Kyaw; Ohn Phe; Thein Win; Pyay Phyo Aung; Aung Pyay Phyo Oo; Arkar Linn Naing; Mya Yee Nyo; Naing Zaw Htun Myint; Mallika Imwong; Elizabeth Ashley; Sue J Lee; Nicholas J White
Journal:  Lancet Infect Dis       Date:  2010-09-09       Impact factor: 25.071

8.  High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand.

Authors:  S Looareesuwan; N J White; S Chittamas; D Bunnag; T Harinasuta
Journal:  Lancet       Date:  1987-11-07       Impact factor: 79.321

9.  An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.

Authors:  Neena Valecha; Aung Pyae Phyo; Mayfong Mayxay; Paul N Newton; Srivicha Krudsood; Sommay Keomany; Maniphone Khanthavong; Tiengkham Pongvongsa; Ronnatrai Ruangveerayuth; Chirapong Uthaisil; David Ubben; Stephan Duparc; Antonella Bacchieri; Marco Corsi; Bappanad H K Rao; Prabash C Bhattacharya; Nagesh Dubhashi; Susanta K Ghosh; Vas Dev; Ashwani Kumar; Sasithon Pukrittayakamee; Sasithon Pukittayakamee
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

10.  Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity.

Authors:  Kasia Stepniewska; Ric N Price; Colin J Sutherland; Chris J Drakeley; Lorenz von Seidlein; Francois Nosten; Nicholas J White
Journal:  Malar J       Date:  2008-12-03       Impact factor: 2.979
View more
  1 in total

1.  Plasmodium falciparum gametocyte carriage is associated with subsequent Plasmodium vivax relapse after treatment.

Authors:  Jessica T Lin; Delia Bethell; Stuart D Tyner; Chanthap Lon; Naman K Shah; David L Saunders; Sabaithip Sriwichai; Phisit Khemawoot; Worachet Kuntawunggin; Bryan L Smith; Harald Noedl; Kurt Schaecher; Duong Socheat; Youry Se; Steven R Meshnick; Mark M Fukuda
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.